Dr. Morolake Amole, MD
What this data tells you about Dr. Amole
Dr. Morolake Amole is an endocrinology in West Palm Beach, FL, with 11 years in practice. Based on federal Medicare data, Dr. Amole performed 5,426 Medicare services across 2,740 unique beneficiaries.
Between the years covered by Open Payments, Dr. Amole received a total of $8,858 from 49 pharmaceutical and/or device companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amole is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 619 | $91 | $205 |
| Blood draw (venipuncture) | 562 | $8 | $10 |
| Comprehensive metabolic blood panel | 510 | $10 | $60 |
| Thyroid stimulating hormone (TSH) test | 363 | $16 | $48 |
| Lipid panel (cholesterol and triglycerides) | 362 | $13 | $38 |
| Chronic care management, first 20 min/month | 303 | $47 | $100 |
| Free thyroxine (T4) test | 275 | $9 | $30 |
| Blood glucose (sugar) measurement using reagent strip | 273 | $5 | $6 |
| Complete blood count (CBC) with differential | 263 | $8 | $50 |
| Glycated protein level | 243 | $16 | $43 |
| Creatinine test (kidney function) | 222 | $5 | $15 |
| Urine microalbumin (protein) analysis | 221 | $6 | $17 |
| Hemoglobin A1c test (diabetes monitoring) | 124 | $9 | $28 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 109 | $26 | $86 |
| Remote patient monitoring management, 20 min/month | 95 | $37 | $120 |
| Ultrasound scan of head and neck soft tissue | 87 | $84 | $224 |
| Vitamin D level test | 85 | $29 | $80 |
| Thyroid hormone, t3 measurement, free | 82 | $16 | $45 |
| Carbohydrate analysis, single quantitative | 74 | $11 | $40 |
| New patient office visit (45-59 min) | 60 | $122 | $318 |
| Office visit, established patient (20-29 min) | 54 | $67 | $136 |
| Parathyroid hormone level test | 50 | $40 | $118 |
| Vitamin B-12 level test | 46 | $15 | $40 |
| Diabetes outpatient self-management training services, individual, per 30 minutes | 46 | $38 | $100 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 44 | $112 | $300 |
| Remote patient monitoring device, 30 days | 39 | $36 | $110 |
| Thyroglobulin (thyroid protein) antibody measurement | 32 | $16 | $60 |
| Microsomal antibodies (autoantibody) measurement | 26 | $14 | $50 |
| Cortisol (hormone) measurement, total | 23 | $16 | $47 |
| Chronic care management, additional 20 min/month | 23 | $38 | $80 |
| Adrenocorticotropic hormone (acth) level | 22 | $38 | $111 |
| Dehydroepiandrosterone (dhea-s) hormone level | 21 | $21 | $64 |
| Phosphate level test | 19 | $5 | $14 |
| C-peptide (protein) level | 19 | $20 | $55 |
| Automated urinalysis | 16 | $2 | $10 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 14 | $50 | $150 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Amole is a clinical cardiology specialist, with above-average Medicare volume (top 11% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Amole experienced with office visit, established patient (30-39 min)?
Does Dr. Amole receive payments from pharmaceutical companies?
How do Dr. Amole's costs compare to other endocrinologys in West Palm Beach?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology